Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Skeletal | 18 | 2024 | 4947 | 1.740 |
Why?
|
Regeneration | 9 | 2024 | 1505 | 1.680 |
Why?
|
Muscular Diseases | 3 | 2023 | 553 | 1.670 |
Why?
|
Satellite Cells, Skeletal Muscle | 3 | 2023 | 126 | 1.140 |
Why?
|
Tissue Scaffolds | 7 | 2024 | 932 | 0.970 |
Why?
|
Teichoic Acids | 1 | 2024 | 70 | 0.910 |
Why?
|
Wound Healing | 6 | 2024 | 2802 | 0.900 |
Why?
|
Musculoskeletal Physiological Phenomena | 1 | 2023 | 31 | 0.880 |
Why?
|
Burns | 10 | 2018 | 1875 | 0.850 |
Why?
|
Rhytidoplasty | 1 | 2024 | 71 | 0.850 |
Why?
|
Mammaplasty | 6 | 2023 | 1232 | 0.780 |
Why?
|
Muscle Development | 6 | 2020 | 259 | 0.750 |
Why?
|
Sarcopenia | 3 | 2023 | 370 | 0.740 |
Why?
|
Mastectomy | 4 | 2023 | 1817 | 0.730 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 37 | 0.720 |
Why?
|
Skin Transplantation | 5 | 2018 | 1083 | 0.710 |
Why?
|
Contracture | 3 | 2024 | 235 | 0.710 |
Why?
|
Surgical Wound Infection | 3 | 2018 | 1529 | 0.680 |
Why?
|
Fibrosis | 6 | 2023 | 2045 | 0.680 |
Why?
|
Guided Tissue Regeneration | 1 | 2019 | 88 | 0.650 |
Why?
|
Nanostructures | 1 | 2024 | 551 | 0.640 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2006 | 1228 | 0.620 |
Why?
|
Occlusive Dressings | 1 | 2018 | 52 | 0.620 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 155 | 0.610 |
Why?
|
Surgical Flaps | 7 | 2023 | 1670 | 0.600 |
Why?
|
Breast Implantation | 2 | 2017 | 219 | 0.580 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 1932 | 0.570 |
Why?
|
Chitosan | 1 | 2018 | 131 | 0.560 |
Why?
|
Matrix Metalloproteinase 9 | 7 | 2006 | 632 | 0.550 |
Why?
|
Lipopolysaccharides | 1 | 2024 | 2202 | 0.540 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2023 | 3492 | 0.520 |
Why?
|
Matrix Metalloproteinase 2 | 4 | 2006 | 459 | 0.490 |
Why?
|
Facial Transplantation | 4 | 2021 | 221 | 0.470 |
Why?
|
Parabiosis | 1 | 2014 | 64 | 0.460 |
Why?
|
Tissue Engineering | 5 | 2024 | 1865 | 0.410 |
Why?
|
Pancreatic Elastase | 6 | 2006 | 127 | 0.410 |
Why?
|
Immunity, Innate | 2 | 2024 | 3045 | 0.400 |
Why?
|
Cartoons as Topic | 1 | 2011 | 15 | 0.390 |
Why?
|
Osteosarcoma | 1 | 2016 | 896 | 0.340 |
Why?
|
Animals | 40 | 2024 | 168201 | 0.340 |
Why?
|
Recovery of Function | 2 | 2019 | 2978 | 0.330 |
Why?
|
Aging | 6 | 2023 | 8699 | 0.330 |
Why?
|
Glycosaminoglycans | 2 | 2023 | 607 | 0.310 |
Why?
|
Cell Cycle | 1 | 2016 | 2930 | 0.290 |
Why?
|
Mice | 23 | 2024 | 81368 | 0.290 |
Why?
|
Breast Implants | 2 | 2024 | 407 | 0.290 |
Why?
|
Child Welfare | 1 | 2011 | 521 | 0.280 |
Why?
|
Muscle Fibers, Skeletal | 5 | 2018 | 542 | 0.270 |
Why?
|
Rats, Sprague-Dawley | 9 | 2023 | 8166 | 0.270 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9417 | 0.260 |
Why?
|
Breast | 1 | 2015 | 1963 | 0.260 |
Why?
|
Nitroso Compounds | 1 | 2006 | 71 | 0.260 |
Why?
|
Testosterone | 2 | 2014 | 2472 | 0.250 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 126 | 0.250 |
Why?
|
Facial Injuries | 2 | 2017 | 190 | 0.250 |
Why?
|
Health Education | 1 | 2011 | 1049 | 0.240 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2006 | 1169 | 0.240 |
Why?
|
Postoperative Complications | 4 | 2024 | 15612 | 0.230 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2023 | 748 | 0.230 |
Why?
|
Muscular Atrophy | 2 | 2024 | 334 | 0.230 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 593 | 0.230 |
Why?
|
Muscle Strength | 2 | 2019 | 624 | 0.230 |
Why?
|
Cell Movement | 4 | 2018 | 5200 | 0.230 |
Why?
|
Adipose Tissue | 1 | 2016 | 3309 | 0.230 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2527 | 0.220 |
Why?
|
Cell Proliferation | 2 | 2017 | 10432 | 0.220 |
Why?
|
Collagen | 2 | 2023 | 2634 | 0.210 |
Why?
|
Organ Size | 3 | 2019 | 2252 | 0.210 |
Why?
|
Rats | 11 | 2023 | 23717 | 0.210 |
Why?
|
Rejuvenation | 1 | 2024 | 105 | 0.210 |
Why?
|
Metalloendopeptidases | 1 | 2004 | 393 | 0.200 |
Why?
|
NF-kappa B | 2 | 2024 | 2481 | 0.200 |
Why?
|
Polyesters | 1 | 2024 | 371 | 0.200 |
Why?
|
Porosity | 1 | 2023 | 348 | 0.200 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 22115 | 0.190 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 368 | 0.190 |
Why?
|
Surgery, Plastic | 3 | 2016 | 641 | 0.190 |
Why?
|
India | 5 | 2016 | 2286 | 0.190 |
Why?
|
Estrogen Receptor beta | 1 | 2022 | 168 | 0.190 |
Why?
|
Breast Neoplasms | 7 | 2023 | 20988 | 0.190 |
Why?
|
Disease Models, Animal | 8 | 2024 | 18221 | 0.180 |
Why?
|
Cicatrix | 2 | 2024 | 785 | 0.170 |
Why?
|
Wounds and Injuries | 3 | 2021 | 2491 | 0.170 |
Why?
|
Signal Transduction | 6 | 2024 | 23416 | 0.160 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2006 | 696 | 0.160 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 530 | 0.160 |
Why?
|
Health Promotion | 1 | 2011 | 2206 | 0.160 |
Why?
|
Hematoma | 1 | 2024 | 762 | 0.160 |
Why?
|
Skin Pigmentation | 1 | 2021 | 277 | 0.160 |
Why?
|
Neuromuscular Junction | 1 | 2021 | 405 | 0.160 |
Why?
|
Leukocytes | 1 | 2006 | 2023 | 0.150 |
Why?
|
Stromal Cells | 1 | 2024 | 1329 | 0.150 |
Why?
|
Ischemic Preconditioning | 1 | 2018 | 89 | 0.150 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 583 | 0.150 |
Why?
|
Replantation | 1 | 2018 | 145 | 0.140 |
Why?
|
Lymphedema | 1 | 2023 | 523 | 0.140 |
Why?
|
Rectus Abdominis | 2 | 2023 | 103 | 0.140 |
Why?
|
Fetus | 2 | 2014 | 1862 | 0.130 |
Why?
|
Keratinocytes | 2 | 2018 | 790 | 0.130 |
Why?
|
Thyroid Hormone Receptors alpha | 1 | 2016 | 13 | 0.130 |
Why?
|
Sex Characteristics | 1 | 2006 | 2637 | 0.130 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2016 | 59 | 0.130 |
Why?
|
Pentylenetetrazole | 1 | 2016 | 71 | 0.130 |
Why?
|
Nutritional Requirements | 1 | 2017 | 274 | 0.130 |
Why?
|
Oxidative Stress | 1 | 2006 | 3113 | 0.130 |
Why?
|
Humans | 43 | 2024 | 760617 | 0.120 |
Why?
|
Transplantation, Homologous | 4 | 2021 | 4804 | 0.120 |
Why?
|
Aorta, Abdominal | 3 | 2006 | 625 | 0.120 |
Why?
|
Organ Preservation | 1 | 2018 | 382 | 0.120 |
Why?
|
rho-Associated Kinases | 1 | 2016 | 281 | 0.120 |
Why?
|
Hypertrophy | 2 | 2014 | 560 | 0.120 |
Why?
|
Time Factors | 6 | 2018 | 39913 | 0.120 |
Why?
|
Transplantation, Autologous | 2 | 2018 | 2112 | 0.120 |
Why?
|
Graft Survival | 4 | 2018 | 3820 | 0.110 |
Why?
|
Stem Cells | 3 | 2023 | 3516 | 0.110 |
Why?
|
Diseases in Twins | 1 | 2015 | 446 | 0.110 |
Why?
|
Female | 26 | 2024 | 392148 | 0.110 |
Why?
|
Neutrophil Infiltration | 2 | 2006 | 390 | 0.110 |
Why?
|
Wrist Injuries | 1 | 2015 | 214 | 0.110 |
Why?
|
Apoptosis | 3 | 2022 | 9476 | 0.110 |
Why?
|
Thyroid Hormones | 1 | 2016 | 403 | 0.110 |
Why?
|
Bronchodilator Agents | 1 | 2016 | 512 | 0.110 |
Why?
|
Hand Injuries | 1 | 2015 | 239 | 0.100 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 11874 | 0.100 |
Why?
|
Extremities | 1 | 2018 | 867 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2024 | 64568 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1850 | 0.100 |
Why?
|
Kerosene | 1 | 2012 | 15 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1086 | 0.100 |
Why?
|
Graft Rejection | 3 | 2021 | 4446 | 0.100 |
Why?
|
Cells, Cultured | 9 | 2018 | 18937 | 0.100 |
Why?
|
Enzyme Activation | 3 | 2009 | 3591 | 0.100 |
Why?
|
Mitochondria | 1 | 2005 | 3619 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1389 | 0.100 |
Why?
|
Gene Expression | 3 | 2021 | 7568 | 0.100 |
Why?
|
West Virginia | 1 | 2011 | 32 | 0.100 |
Why?
|
Postoperative Care | 1 | 2018 | 1467 | 0.100 |
Why?
|
Mice, Knockout | 3 | 2024 | 14389 | 0.100 |
Why?
|
Cytokines | 1 | 2006 | 7373 | 0.100 |
Why?
|
Male | 24 | 2023 | 360358 | 0.100 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 574 | 0.090 |
Why?
|
Enteral Nutrition | 1 | 2017 | 794 | 0.090 |
Why?
|
Thoracic Wall | 1 | 2013 | 202 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2016 | 1088 | 0.090 |
Why?
|
Hypothyroidism | 1 | 2016 | 667 | 0.090 |
Why?
|
Osteogenesis | 2 | 2014 | 1270 | 0.090 |
Why?
|
Perfusion | 3 | 2018 | 1373 | 0.090 |
Why?
|
Workload | 1 | 2016 | 844 | 0.090 |
Why?
|
Fibroblasts | 2 | 2018 | 4137 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2456 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2018 | 2894 | 0.080 |
Why?
|
Irritants | 1 | 2009 | 43 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1037 | 0.080 |
Why?
|
Receptors, Notch | 1 | 2014 | 743 | 0.080 |
Why?
|
Dioxoles | 1 | 2009 | 95 | 0.080 |
Why?
|
Tetrahydroisoquinolines | 1 | 2009 | 81 | 0.080 |
Why?
|
Cell Line | 2 | 2020 | 15576 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2016 | 1262 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2006 | 1492 | 0.080 |
Why?
|
Chronic Disease | 1 | 2024 | 9311 | 0.080 |
Why?
|
Myostatin | 1 | 2009 | 129 | 0.080 |
Why?
|
Memory Disorders | 1 | 2016 | 1197 | 0.080 |
Why?
|
Skin Ulcer | 1 | 2009 | 130 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 438 | 0.070 |
Why?
|
Epigastric Arteries | 2 | 2023 | 92 | 0.070 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 172 | 0.070 |
Why?
|
Pilot Projects | 2 | 2018 | 8618 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1667 | 0.070 |
Why?
|
Earthquakes | 1 | 2010 | 191 | 0.070 |
Why?
|
Child, Preschool | 6 | 2020 | 42188 | 0.070 |
Why?
|
Reading | 1 | 2011 | 531 | 0.070 |
Why?
|
Patient Preference | 1 | 2015 | 925 | 0.070 |
Why?
|
International Cooperation | 2 | 2011 | 1421 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 1642 | 0.070 |
Why?
|
Immunohistochemistry | 5 | 2014 | 11069 | 0.070 |
Why?
|
Cyclic N-Oxides | 1 | 2006 | 72 | 0.070 |
Why?
|
Cell Differentiation | 3 | 2020 | 11514 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1650 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3777 | 0.070 |
Why?
|
Burn Units | 2 | 2017 | 143 | 0.070 |
Why?
|
Hydrogels | 2 | 2024 | 720 | 0.070 |
Why?
|
Bariatric Surgery | 1 | 2015 | 992 | 0.060 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 422 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2878 | 0.060 |
Why?
|
Caspase 9 | 1 | 2005 | 184 | 0.060 |
Why?
|
Spin Labels | 1 | 2006 | 337 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 13245 | 0.060 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2004 | 14 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1921 | 0.060 |
Why?
|
Developing Countries | 3 | 2012 | 2867 | 0.060 |
Why?
|
Catalase | 1 | 2005 | 218 | 0.060 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 794 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2005 | 131 | 0.060 |
Why?
|
Dilatation, Pathologic | 1 | 2006 | 527 | 0.060 |
Why?
|
Disasters | 1 | 2010 | 519 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8542 | 0.060 |
Why?
|
P-Selectin | 1 | 2006 | 599 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2006 | 12758 | 0.060 |
Why?
|
Patient Satisfaction | 3 | 2013 | 3451 | 0.060 |
Why?
|
Adolescent | 6 | 2020 | 88234 | 0.060 |
Why?
|
Young Adult | 5 | 2017 | 59179 | 0.060 |
Why?
|
Adult | 10 | 2018 | 220969 | 0.060 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 730 | 0.050 |
Why?
|
Caspase 3 | 1 | 2005 | 731 | 0.050 |
Why?
|
Antigens, Ly | 1 | 2024 | 294 | 0.050 |
Why?
|
Reoperation | 3 | 2021 | 4300 | 0.050 |
Why?
|
Caspases | 1 | 2005 | 878 | 0.050 |
Why?
|
Schools | 1 | 2011 | 1483 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2007 | 1130 | 0.050 |
Why?
|
Drug Implants | 2 | 2018 | 230 | 0.050 |
Why?
|
Child | 6 | 2020 | 80079 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2561 | 0.050 |
Why?
|
Fat Necrosis | 2 | 2013 | 60 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2006 | 648 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4391 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2005 | 1081 | 0.050 |
Why?
|
Students | 1 | 2011 | 1733 | 0.050 |
Why?
|
Adipogenesis | 2 | 2014 | 366 | 0.050 |
Why?
|
Injury Severity Score | 2 | 2017 | 1045 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2007 | 3088 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39063 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2006 | 998 | 0.050 |
Why?
|
PPAR gamma | 1 | 2023 | 484 | 0.050 |
Why?
|
Up-Regulation | 2 | 2006 | 4117 | 0.040 |
Why?
|
Necrosis | 2 | 2018 | 1610 | 0.040 |
Why?
|
Tamoxifen | 1 | 2005 | 965 | 0.040 |
Why?
|
Neutropenia | 1 | 2005 | 885 | 0.040 |
Why?
|
Aged | 6 | 2021 | 169042 | 0.040 |
Why?
|
Inflammation | 2 | 2018 | 10760 | 0.040 |
Why?
|
Transfection | 2 | 2018 | 5766 | 0.040 |
Why?
|
Swine | 2 | 2021 | 5907 | 0.040 |
Why?
|
Middle Aged | 7 | 2018 | 220584 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8207 | 0.040 |
Why?
|
Estrogens | 2 | 2022 | 1521 | 0.040 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2021 | 278 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1668 | 0.040 |
Why?
|
Neovascularization, Physiologic | 2 | 2021 | 1349 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 2915 | 0.040 |
Why?
|
Ink | 1 | 2018 | 47 | 0.040 |
Why?
|
Mice, Obese | 1 | 2018 | 418 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2016 | 1697 | 0.040 |
Why?
|
Suction | 1 | 2018 | 266 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 6233 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29600 | 0.040 |
Why?
|
Tissue Expansion | 1 | 2018 | 160 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 41457 | 0.040 |
Why?
|
Sodium Salicylate | 1 | 2016 | 18 | 0.040 |
Why?
|
Skin Physiological Phenomena | 1 | 2018 | 188 | 0.040 |
Why?
|
Paracrine Communication | 1 | 2018 | 277 | 0.040 |
Why?
|
Anniversaries and Special Events | 1 | 2017 | 95 | 0.030 |
Why?
|
Biliopancreatic Diversion | 1 | 2015 | 15 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2018 | 1759 | 0.030 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2016 | 111 | 0.030 |
Why?
|
France | 1 | 2017 | 492 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5878 | 0.030 |
Why?
|
Receptors, Steroid | 1 | 2016 | 156 | 0.030 |
Why?
|
Program Development | 2 | 2013 | 1293 | 0.030 |
Why?
|
Esthetics | 1 | 2017 | 327 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 12142 | 0.030 |
Why?
|
Platelet-Rich Plasma | 1 | 2018 | 178 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3268 | 0.030 |
Why?
|
Stem Cell Transplantation | 2 | 2014 | 1600 | 0.030 |
Why?
|
CA1 Region, Hippocampal | 1 | 2016 | 109 | 0.030 |
Why?
|
Body Surface Area | 1 | 2015 | 197 | 0.030 |
Why?
|
Needs Assessment | 2 | 2012 | 1139 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1937 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3548 | 0.030 |
Why?
|
Cell Lineage | 2 | 2014 | 2554 | 0.030 |
Why?
|
Cold Temperature | 1 | 2018 | 784 | 0.030 |
Why?
|
Macrophages | 2 | 2006 | 5758 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2016 | 495 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2016 | 369 | 0.030 |
Why?
|
Infant | 4 | 2020 | 36152 | 0.030 |
Why?
|
Time | 1 | 2016 | 545 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 578 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2016 | 290 | 0.030 |
Why?
|
PAX7 Transcription Factor | 1 | 2014 | 55 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2018 | 1848 | 0.030 |
Why?
|
Dendritic Spines | 1 | 2016 | 242 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2015 | 478 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1813 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2014 | 351 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10754 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58894 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2014 | 95 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1156 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9529 | 0.030 |
Why?
|
Pyramidal Cells | 1 | 2016 | 366 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2016 | 344 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5863 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2756 | 0.030 |
Why?
|
Efficiency | 1 | 2016 | 476 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1162 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2023 | 80566 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1379 | 0.030 |
Why?
|
Neutrophils | 1 | 2005 | 3763 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4237 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1117 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2017 | 2495 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 11669 | 0.030 |
Why?
|
Work Schedule Tolerance | 1 | 2016 | 552 | 0.020 |
Why?
|
Homozygote | 1 | 2016 | 1776 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22131 | 0.020 |
Why?
|
Burns, Chemical | 1 | 2012 | 123 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1662 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2381 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 74115 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2016 | 1169 | 0.020 |
Why?
|
Hernia, Abdominal | 1 | 2010 | 56 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2635 | 0.020 |
Why?
|
Donor Selection | 1 | 2011 | 232 | 0.020 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 101 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2014 | 1865 | 0.020 |
Why?
|
Haiti | 1 | 2010 | 550 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2446 | 0.020 |
Why?
|
Cell Separation | 1 | 2014 | 1718 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1896 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2006 | 22148 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2830 | 0.020 |
Why?
|
Risk Assessment | 3 | 2017 | 23972 | 0.020 |
Why?
|
Leptin | 1 | 2015 | 1595 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1745 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 21337 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1656 | 0.020 |
Why?
|
Aorta | 2 | 2005 | 2041 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5780 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2010 | 311 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2270 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6305 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3769 | 0.020 |
Why?
|
Glucose | 1 | 2018 | 4345 | 0.020 |
Why?
|
Military Personnel | 1 | 2015 | 1245 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 890 | 0.020 |
Why?
|
Cricetulus | 1 | 2007 | 814 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 26180 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2506 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 617 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16967 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2014 | 2382 | 0.020 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2005 | 56 | 0.020 |
Why?
|
Amitrole | 1 | 2005 | 8 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 151 | 0.020 |
Why?
|
CHO Cells | 1 | 2007 | 1387 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2849 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5780 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2012 | 1835 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2214 | 0.010 |
Why?
|
Critical Care | 1 | 2017 | 2690 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 526 | 0.010 |
Why?
|
Device Removal | 1 | 2009 | 629 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4174 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2010 | 969 | 0.010 |
Why?
|
Skin | 1 | 2018 | 4473 | 0.010 |
Why?
|
Cricetinae | 1 | 2007 | 2424 | 0.010 |
Why?
|
Echocardiography | 1 | 2016 | 4987 | 0.010 |
Why?
|
Drainage | 1 | 2009 | 1156 | 0.010 |
Why?
|
Physician's Role | 1 | 2010 | 917 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2005 | 602 | 0.010 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2005 | 289 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 3998 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4408 | 0.010 |
Why?
|
Dogs | 1 | 2007 | 3838 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3608 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20556 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6961 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2668 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2015 | 3742 | 0.010 |
Why?
|
Low Back Pain | 1 | 2010 | 982 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 1966 | 0.010 |
Why?
|
Retinal Vessels | 1 | 2007 | 852 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6418 | 0.010 |
Why?
|
Cost of Illness | 1 | 2011 | 1935 | 0.010 |
Why?
|
Sex Factors | 2 | 2005 | 10548 | 0.010 |
Why?
|
Cell Communication | 1 | 2007 | 1654 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5672 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18381 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13347 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2011 | 1924 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16571 | 0.010 |
Why?
|
Health Policy | 1 | 2011 | 2682 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7798 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4570 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5034 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9345 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17878 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29868 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 12933 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2011 | 5430 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15828 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54360 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 30016 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26049 | 0.010 |
Why?
|